Carole Huntsman, Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 419 shares at $431.94 ($181K) on 2026-03-06, disclosed to the SEC on 2026-03-06.
Open-market sale of $181k MDGL by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MDGL | SELL | 2025-03-05 | $727K | — | Filing → |
| MDGL | SELL | 2025-01-27 | $233K | — | Filing → |
| MDGL | SELL | 2024-11-22 | $436K | — | Filing → |